Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Open Enrollment Season: What Employers and Employees Need to Know Before it Ends

Employers and employees are in the thick of open enrollment season, and the end date is coming to close. For the ACA marketplace, for example, open enrollment ends on January 15, 2023. Overall, companies are going to have to make important decisions about what health insurance they offer to employees, and employees will need to…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Employers and employees are in the thick of open enrollment season, and the end date is coming to close. For the ACA marketplace, for example, open enrollment ends on January 15, 2023. Overall, companies are going to have to make important decisions about what health insurance they offer to employees, and employees will need to wade through the options to figure out which plans best suit their needs, whether those are ACA-offered, employer-offered, or otherwise.

Nick Love, a Benefit Strategist at Brinson Benefits breaks down what beneficiaries need to know about this year’s open enrollment seasons, along with some other tips, misconceptions and more for employers and employees alike.

Nick’s Thoughts:

“We typically see employers just not take open enrollment seriously. Unfortunately, that has a pretty big impact for employees in their households. So, I would encourage employers to take open enrollment, seriously, and for employees as well. Take your time evaluating all the options that you have at your disposal.

Compare what your spouse or significant other has through their employer and make the best decision for you and your family based on the things being offered to both you and your spouse. One thing to keep in mind is whatever you decide at open enrollment remains in effect for a full year unless you have a qualifying life event, which, usually includes things like getting married, getting divorced, having a child, those sort of things.

And so, when that happens, you have a very specific timeframe to notify HR. And so that, that timeframe is 30 days. Make sure you do that within that range so that you can make those mid-year. I would say education’s a big deal. Understanding what deductibles are, what co-insurance means what it’s gonna cost when you go to the doctor, those sort of things.

Some of the things that I think we’re gonna see more of in 2023 are folks gravitating towards HSA plans and more, taking on more of a responsibility in terms of what it’s gonna cost them when they go to the doctor and how they’re going to use that information to make the best decision as to where to go, when to go.

I think we’re gonna continue to see telemedicine have a big impact on people’s decisions and really leaning on the ability to speak to a provider via a telephone or through your computer and not having to physically go to a doctor’s office.”

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512